2019
DOI: 10.1016/j.biologicals.2019.01.001
|View full text |Cite
|
Sign up to set email alerts
|

An ELISA using a recombinant chimera of protective antigen and lethal factor for serodiagnosis of cutaneous anthrax in India

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 33 publications
0
5
0
Order By: Relevance
“…EF can convert up to 2000 molecules of ATP to cAMP per second, significantly increasing the concentration of this classical second messenger, thereby causing diverse effects [52]. There are three forms of anthrax (inhalational, gastrointestinal, and cutaneous) depending on the route of exposure to B. anthracis [53]. Inhalational anthrax is considered to be the most fatal form of anthrax.…”
Section: Bacillus Anthracismentioning
confidence: 99%
“…EF can convert up to 2000 molecules of ATP to cAMP per second, significantly increasing the concentration of this classical second messenger, thereby causing diverse effects [52]. There are three forms of anthrax (inhalational, gastrointestinal, and cutaneous) depending on the route of exposure to B. anthracis [53]. Inhalational anthrax is considered to be the most fatal form of anthrax.…”
Section: Bacillus Anthracismentioning
confidence: 99%
“…Laboratory testing is required to confirm the diagnosis, and the detection of anthrax protective antigen (PA) has been found to be an important biological marker for anthrax [5]. However, existing PA detection technologies include enzyme-linked immunosorbent assays (ELISAs) [6], immunomagnetic beads (IMBs) [7,8], homogenous time-resolved fluorescence (HTRF) [9,10], and biosensors [11][12][13][14], which can only detect nanogram-or picogram-level concentrations of PA and have problems such as cumbersome operation steps, a large instrument volume, and high consumable prices that cannot be solved in the short term.…”
Section: Introductionmentioning
confidence: 99%
“…Multiepitope antigens have been widely used for toxoplasmosis diagnosis; for example, synthetic multiepitope antigens are applied to detect anti-T. gondii IgG and IgM, and AMA1-SAG2-GRA1-ROP1 chimeric antigens are used to detect specific antibodies of human and mouse in early and chronic T. gondii infection [21]. Chimeric antigen technology has been developed for the serological diagnosis of Trypanosoma cruzi infection caused by another protozoan parasite, cutaneous anthrax caused by Bacillus anthracis, and others [22][23][24]. However, few studies have been conducted to evaluate chimeric antigens for serodiagnosis of T. gondii in pigs and to design an ELISA kit using synthetic antigens for the large-scale diagnosis of toxoplasmosis in pig farms and intensive industries.…”
Section: Introductionmentioning
confidence: 99%